About Attagene
Attagene is a Healthcare company based in Morrisville (United States) founded in 2001. Molecular technologies for cell signaling analysis are developed. The company has 6 employees. Attagene offers products and services including FACTORIAL™, TF FACTORIAL™, Multireporter Mouse™, and NR FACTORIAL™. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its legal entity is ATTAGENE, INC. Its competitors include Lucid Scientific, Kiyatec and CytoTronics; 3 of its 3 listed competitors have raised funding.
Company details
Attagene is dedicated to developing molecular technologies for systematic analysis of cell signaling. Attagenes flagship technology is FACTORIAL a platform which can assess activities of practically unlimited numbers of transcription factors (TFs) within a cell required for the characterization of cellular gene regulatory network. The technology involves reporter DNA constructs called reporter transcription units (RTUs) which when transfected into the cell get transcribed into reporter RNAs that mirror the activity of evaluated transcription factors. These reporter RNAs are then amplified by fluorescently labeled RT-PCR followed by HpaI digestion and capillary electrophoresis resolution. The fluorescent peaks thus obtained are proportional to activities of evaluated TFs. Based on this technology the company has developed two cell based assays called Cis-FACTORIAL assays report which effects of compounds on activities of over 90 transcription factor (TF) families in toxicologically-relevant human and animal cell lines and primary cells and Trans-FACTORIAL assays which evaluate agonisticantagonistic properties of compounds against all 48 human nuclear hormone receptors.
- Headquarters Morrisville, United States
- Employees 6
- SectorsHealthcare
- Website attagene.com
- Social Facebook
- Legal Name Attagene, Inc.
- Latest Funding Round$2M (USD), Grant
Sep 2023
- Investors
- Employee Count6
Products & Services of Attagene
Attagene offers a comprehensive portfolio of products and services, including FACTORIAL™, TF FACTORIAL™, Multireporter Mouse™, and NR FACTORIAL™.
Platform for high-content assessment of gene regulatory pathways in live cells.
Profiles activities of over 90 transcription factors in human and animal cells.
Enables profiling of transcription factors in mouse liver systems.
Assesses agonist and antagonist activities against human nuclear receptors.
Funding Insights of Attagene
- Total Rounds 3
- Last Round Grant — $2M
- First Round $2.99M
(Aug 2017)
- Investors Count 1
All 3 funding rounds of Attagene with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Attagene
Attagene has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Attagene
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Attagene
3 dated milestones of Attagene across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Attagene is founded.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Grant, of $2.0M.
Competitors of Attagene
Attagene has 3 listed competitors in our database, 3 of them funded. They include Lucid Scientific, Kiyatec and CytoTronics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lucidsci.com | 2012 | Atlanta, United States | $12.73M | Real-time cell analyzers are developed for oxygen consumption monitoring. | ||
| kiyatec.com | 2005 | Pendleton, United States | $29.49M | Kiyatec is focused on revolutionizing cancer care through predictive platforms. | ||
| cytotronics.com | 2015 | Boston, United States | $22.75M | 22 | Cell-based assays for drug discovery are developed via CMOS platform. |
Detailed competitors of Attagene
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Attagene
Websites that share an audience with Attagene (attagene.com).
Websites whose visitors overlap most with Attagene. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| toxicology.org | 100% | 70.9K | #483,570 | View details | |
furlonglab.embl.de | furlonglab.embl.de | 94% | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Attagene (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Attagene
Attagene was founded in 2001 and raised its 1st funding round 16 years after it was founded.
Attagene is headquartered in Morrisville, United States.
Attagene has 6 employees.
Attagene is dedicated to developing molecular technologies for systematic analysis of cell signaling. Attagenes flagship technology is FACTORIAL a platform which can assess activities of practically unlimited numbers of transcription factors (TFs) within a cell required for the characterization of cellular gene regulatory network. The technology involves reporter DNA constructs called reporter transcription units (RTUs) which when transfected into the cell get transcribed into reporter RNAs that mirror the activity of evaluated transcription factors. These reporter RNAs are then amplified by fluorescently labeled RT-PCR followed by HpaI digestion and capillary electrophoresis resolution. The fluorescent peaks thus obtained are proportional to activities of evaluated TFs. Based on this technology the company has developed two cell based assays called Cis-FACTORIAL assays report which effects of compounds on activities of over 90 transcription factor (TF) families in toxicologically-relevant human and animal cell lines and primary cells and Trans-FACTORIAL assays which evaluate agonisticantagonistic properties of compounds against all 48 human nuclear hormone receptors.
Attagene's top competitors include CytoTronics, Kiyatec and Lucid Scientific.
Attagene offers FACTORIAL™, TF FACTORIAL™, Multireporter Mouse™, and NR FACTORIAL™.
Attagene has 1 investor. Key investors include HHS.
Attagene operates through Attagene, Inc..